Association of response to doxycycline and Azithromycin antibiotics therapy and IL-4 gene ( SR8179190) polymorphism in patients with moderate acne vulgaris

Phase 2

Recruiting

• Conditions: Acne vulgaris.; Acne vulgaris; L70.0

• Registration Number: IRCT20230305057631N1
• Lead Sponsor: Gonabad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Acne vulgaris with moderate severity according to the classification system (MAS score)
Acne vulgaris with moderate severity according to vaishampayan classification system
Age over 12 years

Exclusion Criteria

Failure to complete the treatment process by the patient
Occurrence of unusual complications during treatment
The patient's refusal to continue the treatment process

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response to treatment. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: MAS score.;Satisfaction level. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: check list.;Recovery from the doctor's opinion. Timepoint: Before starting the treatment, after the end of the treatment. Method of measurement: Check list.